Exchange Traded Concepts’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Buy
82,416
+72,998
+775% +$1.79M 0.01% 657
2025
Q4
$252K Sell
9,418
-567
-6% -$14.6K ﹤0.01% 1152
2025
Q3
$266K Buy
9,985
+154
+2% +$3.98K ﹤0.01% 1134
2025
Q2
$226K Buy
9,831
+965
+11% +$23.9K ﹤0.01% 1128
2025
Q1
$257K Buy
+8,866
New +$283K ﹤0.01% 886
2024
Q1
Sell
-21,440
Closed -$1.33M 1245
2023
Q4
$1.33M Buy
21,440
+169
+0.8% +$8.88K 0.04% 339
2023
Q3
$978K Sell
21,271
-24,822
-54% -$1.35M 0.03% 394
2023
Q2
$2.65M Sell
46,093
-490
-1% -$21.7K 0.07% 232
2023
Q1
$1.75M Buy
46,583
+9,431
+25% +$309K 0.05% 229
2022
Q4
$1.04M Buy
37,152
+1,135
+3% +$33K 0.03% 305
2022
Q3
$1.01M Sell
36,017
-18,276
-34% -$597K 0.03% 267
2022
Q2
$1.89M Buy
54,293
+1,612
+3% +$57.5K 0.05% 168
2022
Q1
$1.89M Buy
52,681
+27,698
+111% +$785K 0.04% 234
2021
Q4
$582K Buy
+24,983
New +$511K 0.01% 563
2021
Q3
Sell
-57,851
Closed -$1.17M 1101
2021
Q2
$1.17M Buy
57,851
+5,517
+11% +$104K 0.04% 289
2021
Q1
$959K Buy
52,334
+35,769
+216% +$665K 0.04% 300
2020
Q4
$333K Buy
16,565
+756
+5% +$14.7K 0.02% 520
2020
Q3
$296K Buy
+15,809
New +$318K 0.02% 473

Other funds holding AMPH

Exchange Traded Concepts's AMPH Position: Q1 2026 in Review

Exchange Traded Concepts increased its Amphastar Pharmaceuticals (AMPH) stake by 775% in Q1 2026, buying an estimated $1.79M and bringing the position to 82,416 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #657.

Exchange Traded Concepts first reported a position in AMPH in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.65M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Exchange Traded Concepts held 82,416 shares of Amphastar Pharmaceuticals worth $1.61M as of Q1 2026.
  • Exchange Traded Concepts bought 72,998 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.79M.
  • Amphastar Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #657 holding.
  • Exchange Traded Concepts first reported a position in Amphastar Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
  • Exchange Traded Concepts's Amphastar Pharmaceuticals position peaked at $2.65M in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.